Literature DB >> 25249218

Macular telangiectasia type 2 (MacTel) in a 34-year-old patient.

Heleen Nicolai1, Mieke Wirix2, Leigh Spielberg3, Anita Leys1.   

Abstract

We report macular telangiectasia type 2 (MacTel) in a 34-year-old man, the youngest patient so far published with MacTel type 2. The patient presented with metamorphopsia and impaired reading ability. Diagnosis was based on bilateral abnormal macular autofluorescence, perifoveal telangiectasia with fluorescein angiographic hyperfluorescence without cystoid oedema, a small foveal avascular zone, asymmetric configuration of the foveal pit, disruptions in the inner segment/outer segment layer and hyper-reflective haze and spots in the outer nuclear layer. Although MacTel usually manifests with a slowly progressive decrease in visual acuity in the fifth to seventh decades of life, younger patients may occasionally be diagnosed with the disease. Awareness of subtle signs of the condition is essential for early diagnosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25249218      PMCID: PMC4173144          DOI: 10.1136/bcr-2014-204802

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Topographic variation and interocular symmetry of macular choroidal thickness using enhanced depth imaging optical coherence tomography.

Authors:  Fred K Chen; Jonathan Yeoh; Waheeda Rahman; Praveen J Patel; Adnan Tufail; Lyndon Da Cruz
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

2.  First symptoms and their age of onset in macular telangiectasia type 2.

Authors:  Tjebo F C Heeren; Frank G Holz; Peter Charbel Issa
Journal:  Retina       Date:  2014-05       Impact factor: 4.256

3.  Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.

Authors:  Raja Narayanan; Jay Chhablani; Manish Sinha; Vivek Dave; Mudit Tyagi; Rajeev R Pappuru; Baruch D Kuppermann
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

4.  Vertical transmission of macular telangiectasia type 2.

Authors:  Lien Delaere; Leigh Spielberg; Anita M Leys
Journal:  Retin Cases Brief Rep       Date:  2012

5.  Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.

Authors:  Sönke Baumüller; Peter Charbel Issa; Hendrik P N Scholl; Steffen Schmitz-Valckenberg; Frank G Holz
Journal:  Ophthalmology       Date:  2010-06-16       Impact factor: 12.079

6.  Foveal avascular zone in idiopathic juxtafoveolar telangiectasia.

Authors:  A M Mansour; A Schachat
Journal:  Ophthalmologica       Date:  1993       Impact factor: 3.250

7.  Familial asymptomatic macular telangiectasia type 2.

Authors:  Mark C Gillies; Meidong Zhu; Emily Chew; Daniel Barthelmes; Edward Hughes; Haipha Ali; Frank G Holz; Hendrik P N Scholl; Peter Charbel Issa
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

8.  Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

Authors:  J D Gass; B A Blodi
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

9.  Loss of Müller's cells and photoreceptors in macular telangiectasia type 2.

Authors:  Michael B Powner; Mark C Gillies; Meidong Zhu; Kristis Vevis; Alex P Hunyor; Marcus Fruttiger
Journal:  Ophthalmology       Date:  2013-06-12       Impact factor: 12.079

10.  Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.

Authors:  Traci E Clemons; Mark C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Jie Jin Wang; Paul Mitchell; Wishal D Ramdas; Johannes R Vingerling
Journal:  Ophthalmic Epidemiol       Date:  2013-04       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.